Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8146 to 8160 of 8221 results

  1. More people could be offered genetic testing for genes linked to ovarian cancer

    A new draft NICE guideline for inherited ovarian cancer published today (15 September 2023), recommends more people are tested for genes linked to ovarian cancer.

  2. Adapted shoes recommended for people with severe osteoarthritis

    People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.

  3. Targeted treatment for rare form of aggressive lung cancer gets NICE approval

    Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer

  4. New life-extending treatment for rare forms of advanced gastroesophageal cancer

    Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).

  5. More evidence needed to recommend Type 2 diabetes treatment tirzepatide

    More evidence is needed on the clinical and cost-effectiveness of a new treatment option for people with type 2 diabetes before it could be recommended for NHS use

  6. 170,000 people in England to have further treatment choice for preventing migraine attacks

    In final draft guidance published today NICE has recommended atogepant, the first of a new type of oral treatment option for preventing both chronic and episodic migraines, opening the way for up to 170,000 people to choose it on the NHS in England.

  7. Around 4,000 people with sickle cell disease could benefit from a new treatment recommended by NICE

    Improved deal signals NICE recommendation of sickle cell treatment voxelotor.

  8. NICE recommends innovative treatment for severe blood disorder for NHS use

    Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.

  9. NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia

    More than 1,000 people each year will benefit from NICE's recommendation.

  10. New treatment option for adults with obesity and non-diabetic hyperglycaemia

    All eligibility criteria must be met for Liraglutide to be offered.

  11. Women should be offered induced labour earlier than previously advised

    Induced labour should be offered earlier than previously advised to make birth safer for women and their babies, according to draft guidelines published by NICE today (25 May 2021). The updated recommendations strengthen previous advice in the light of new evidence on induction timings.

  12. More people could be treated out of hospital in the NHS's new respiratory hubs and virtual wards

    Consultation launched on draft guidance for the assessment and management of acute respiratory infections in people over 16

  13. Around 100,000 fewer colonoscopies expected to take place each year

    Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.

  14. New treatment option recommended for people with type 2 diabetes

    Around 180,000 people with difficult to manage type 2 diabetes could benefit from tirzepatide as new treatment option for type 2 diabetes.

  15. People at risk of severe COVID-19 to have access to antiviral Paxlovid

    A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be eligible for Paxlovid if they test positive.